Medizintechnik: Syntellix-Tochter MSE: Utz Claassens Forschungschef steht vor Gericht
Ein Ex-Geschäftsführer der Syntellix-Tochter MSE muss sich im Oktober wegen des Verdachts der Insolvenzverschleppung verantworten. Er hält die Vorwürfe für haltlos.
On October 20th, a criminal trial commenced at Clausthal-Zellerfeld's District Court over allegations of insolvency delay. The defendant is Utz Claassen, a former business leader of the Materials Science and Engineering Werkstoffzentrum Clausthal GmbH (MSE). The company is 100% owned by Syntellix AG, founded by the former success manager Utz Claassen, serving as a central production and research site.
The District Court had already issued a fine of over 120 daily rates of 50 euros. If convicted to this extent, the manager would face a criminal record. He appealed the verdict. Presumption of innocence applies. The amounts at stake are minor. As of June 2023, MSE could not settle debts of nearly 17,000 euros, followed by over 25,000 euros remaining outstanding at a Harz bank after MSE terminated its sole business account. Neither the former MSE CEO nor Claassen responded to inquiries.
Written by urgent.news from Handelsblatt's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
